0001062993-23-022023.txt : 20231206 0001062993-23-022023.hdr.sgml : 20231206 20231206160722 ACCESSION NUMBER: 0001062993-23-022023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231204 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pfeiffenberger Brent CENTRAL INDEX KEY: 0002001162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40498 FILM NUMBER: 231469677 MAIL ADDRESS: STREET 1: C/O CENTURY THERAPEUTICS, INC. STREET 2: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Century Therapeutics, Inc. CENTRAL INDEX KEY: 0001850119 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842040295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-981-4000 MAIL ADDRESS: STREET 1: 25 N 38TH STREET, 11TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-04 0001850119 Century Therapeutics, Inc. IPSC 0002001162 Pfeiffenberger Brent C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 1 1 0 0 President and CEO 0 Common Stock 2023-12-04 4 A 0 1173775 0 A 1173775 D Common Stock 2023-12-04 4 A 0 279504 0 A 1453279 D Stock Option (right to buy) 1.61 2023-12-04 4 A 0 573691 0 A 2033-12-04 Common Stock 573691 573691 D Reflects a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs underlying this grant shall vest 25% on December 4, 2024, with the remaining 75% vesting in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, subject to the Reporting Person's continued service through each applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Reflects a grant of RSUs. The RSUs underlying this grant shall vest in full on December 4, 2024, subject to the Reporting Person's continued service through the applicable vesting date. The option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date. /s/ Michael Diem, Attorney-in-Fact 2023-12-06